Safety Profile
Information not yet available for this ingredient profile.
Interactions
Information not yet available for this ingredient profile.
Evidence and Scientific Findings
Ingredient Overview
Millet seed extract is used in hair and nail supplements for its silica and cysteine content. It is very well tolerated with no significant adverse effects or drug interactions documented at standard doses.
Biological and Chemical Classification
- Scientific Name
- Panicum miliaceum
Mechanism of Action
Information not yet available for this ingredient profile.
Clinical Evidence of Effectiveness
Information not yet available for this ingredient profile.
Pharmacokinetics
Information not yet available for this ingredient profile.
Recommended Dosage
Information not yet available for this ingredient profile.
SETI — Scientific Evidence Transparency Index
Executive Summary — Ingredient Assessment
- 10 studies reviewed
- 0 high-quality studies (meta-analysis or RCT)
- Main clinical benefit observed: Specialty
- Evidence consistency: High consistency across studies (100%)
- No significant safety signals identified in the reviewed literature.
The available scientific evidence for Millet Seed Extract indicates notable safety signals that warrant caution. Use should be considered carefully and monitored, particularly in sensitive populations or alongside other medications.
Total SETI Score
High risk| Evidence quality | 10/40 |
| Evidence consistency | 20/20 |
| Safety signals | 0/20 |
| Study recency | 10/10 |
| Evidence transparency | 10/10 |
Evidence Summary
- 10 studies reviewed
- 0 high-quality studies (meta-analysis or systematic review)
- 0 studies identified benefits or no safety concern (GREEN)
- 10 studies reported limited or advisory safety evidence (YELLOW)
Evidence Policy
Only peer-reviewed scientific literature indexed in PubMed or comparable databases is included in this evaluation. Commercial websites, blogs, and marketing materials are excluded. All references include direct traceable links to source documents.
Last updated: 26 მარ 2026, 14:37
Evidence Distribution
-
Observational / other LOW evidence YELLOWExploring the diversity of the CO2-concentrating mechanism (CCM) in different C4 subtypes. ↗Baccolini C et al.. Exploring the diversity of the CO2-concentrating mechanism (CCM) in different C4 subtypes.. J Exp Bot. 2026. PMID:41777160.PMID 41777160 ↗Journal J Exp BotYear 2026Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/41777160/
-
Observational / other LOW evidence YELLOWEarliest millet cultivation reflects steppe connections, dietary flexibility, and resilience in Bronze Age northern Greece. ↗Karanikola K et al.. Earliest millet cultivation reflects steppe connections, dietary flexibility, and resilience in Bronze Age northern Greece.. PLoS One. 2026. PMID:41774731.PMID 41774731 ↗Journal PLoS OneYear 2026Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/41774731/
-
Observational / other LOW evidence YELLOWGenome-wide identification and drought-responsive root expression profiling of the VQ gene family in proso millet (Panicum miliaceum L.). ↗Tan Q et al.. Genome-wide identification and drought-responsive root expression profiling of the VQ gene family in proso millet (Panicum miliaceum L.).. PeerJ. 2026. PMID:41695714.PMID 41695714 ↗Journal PeerJYear 2026Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/41695714/
-
Observational / other LOW evidence YELLOWFlavor quality during fermentation of the specialty product proso millet (Panicum miliaceum L.) thick wine: Insights from microbiome and metabolomics analyses. ↗Wang H et al.. Flavor quality during fermentation of the specialty product proso millet (Panicum miliaceum L.) thick wine: Insights from microbiome and metabolomics analyses.. Food Res Int. 2026. PMID:41360535.PMID 41360535 ↗Journal Food Res IntYear 2026Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/41360535/
-
Observational / other LOW evidence YELLOWResearch note: Proso millet as an alternative grain source in white leghorn pullet diets. ↗Purdum S et al.. Research note: Proso millet as an alternative grain source in white leghorn pullet diets.. Poult Sci. 2026. PMID:41260087.PMID 41260087 ↗Journal Poult SciYear 2026Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/41260087/
-
Observational / other LOW evidence YELLOWPyrene distribution dynamics and its possible degradation pathways in proso millet tissues: an experimental approach. ↗Tarigholizadeh S et al.. Pyrene distribution dynamics and its possible degradation pathways in proso millet tissues: an experimental approach.. Int J Phytoremediation. 2026. PMID:41223087.PMID 41223087 ↗Journal Int J PhytoremediationYear 2026Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/41223087/
-
Observational / other LOW evidence YELLOWThermal desorption GC/MS on human dental calculus detected minute millet consumption in medieval Ukraine. ↗Shoda S et al.. Thermal desorption GC/MS on human dental calculus detected minute millet consumption in medieval Ukraine.. Sci Rep. 2025. PMID:41360916.PMID 41360916 ↗Journal Sci RepYear 2025Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/41360916/
-
Observational / other LOW evidence YELLOWGenome-wide identification and expression analysis of the MBD gene family in Broomcorn millet (Panicum miliaceum) and its response to abiotic stress. ↗Xu Y et al.. Genome-wide identification and expression analysis of the MBD gene family in Broomcorn millet (Panicum miliaceum) and its response to abiotic stress.. BMC Genomics. 2025. PMID:41188717.PMID 41188717 ↗Journal BMC GenomicsYear 2025Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/41188717/
-
Observational / other LOW evidence YELLOWModulating effects of herbicide-safener co-application on rhizosphere microbiota and soil function in proso millet (Panicum miliaceum L.). ↗Feng Y et al.. Modulating effects of herbicide-safener co-application on rhizosphere microbiota and soil function in proso millet (Panicum miliaceum L.).. J Hazard Mater. 2025. PMID:41175754.PMID 41175754 ↗Journal J Hazard MaterYear 2025Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/41175754/
-
Observational / other LOW evidence YELLOWBioprospecting and mode of action of volatile organic compounds from morphospecies of the endophytic fungus Hypoxylon anthochroum in the field of bioherbicides. ↗Roque-Flores G et al.. Bioprospecting and mode of action of volatile organic compounds from morphospecies of the endophytic fungus Hypoxylon anthochroum in the field of bioherbicides.. World J Microbiol Biotechnol. 2025. PMID:41082008.PMID 41082008 ↗Journal World J Microbiol BiotechnolYear 2025Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/41082008/
Score Transparency
0 of 10 approved references (score saturates at 10). More peer-reviewed studies = stronger evidence base.
Method: Q = number of approved references ÷ 10 (capped at 1.0)
Limited — mostly case reports or animal studies
Method: L = mean study-level weight across approved references. Level 1 (meta-analysis / systematic review) = 1.0; Level 2 (RCT) = 0.8; Level 3 (cohort/case-control) = 0.6; Level 4 (case report) = 0.4; Level 5 (animal / in-vitro) = 0.2.
Mixed or neutral — roughly equal benefit and risk signals
Method: D = (sum of risk-scored references − sum of benefit-scored references) ÷ total evidence score, then scaled from [−1, 1] to [0, 1]. 0.0 = pure benefit; 0.5 = neutral; 1.0 = pure risk.
One or more monitoring-level safety signals active
Method: S = 0.5 (neutral baseline) + sum of active signal severity deltas ÷ 10. Severity deltas: Critical = +2.0, High = +1.5, Moderate = +1.0, Low = +0.5. Capped at 1.0.
Final GIRI Score for Millet Seed Extract. Risk level thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.
Full methodology & data sources
The GIRI Score is computed entirely from structured data — no editorial scoring or subjective weighting is applied at any step.
- References: Only approved references are counted. Each reference is assigned an evidence level (L1–L5) and a direction (risk / neutral / benefit) by the reference manager or AI classifier.
- Safety Signals: Sourced from regulatory agencies (FDA, EMA, Health Canada, TGA, and others) and pharmacovigilance databases. Only active signals count toward the score.
- Formula version: GIRI Score v3.7.0 — Q × L × D × S × 10.
- Limitations: The score reflects published evidence and recorded signals as of the last update date. It is not a clinical risk assessment and should not replace advice from a qualified healthcare professional.
Risk Level Classification
Based on available regulatory signals and scientific evidence, this ingredient presents a low safety concern under normal conditions of use.
0–3.0
3.0–5.5
5.5–7.5
7.5–10
The score pin shows exactly where this ingredient falls on the fixed risk scale.
What drove the Low classification for Millet Seed Extract
A score of 1.0 places this ingredient in the Low band. Thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.
0 approved references.
Limited — mostly case reports or animal studies (Level 4–5).
Neutral or mixed — benefit and risk signals roughly balanced.
No active signals — S component is at neutral baseline (0.5), contributing no extra risk weight.
No major regulatory restrictions or advisories recorded across monitored jurisdictions (FDA, EMA, Health Canada, TGA, and others).
How are the Low / Moderate / High / Critical thresholds defined?
The four risk levels are fixed score bands. A score is assigned to exactly one level based on where it falls:
| Level | Score | Meaning |
|---|---|---|
| LOW | 0.0 – 2.9 | Sparse or predominantly beneficial evidence. No active safety alerts. |
| MODERATE | 3.0 – 5.4 | Mixed signals — some risk alongside benefit. Caution at high doses or in sensitive groups. |
| HIGH | 5.5 – 7.4 | Multiple studies or regulatory alerts documenting adverse effects. Professional oversight recommended. |
| CRITICAL | 7.5 – 10 | Regulatory restrictions in one or more major jurisdictions. Serious documented harm. Avoid without specialist supervision. |
Thresholds are fixed constants (GIRI_Score_Utils::LEVEL_THRESHOLDS). They do not change per ingredient and are never subject to editorial adjustment.